Archive July

Archive for July, 2019

$TGODF Aims to Establish Significant Presence in Global Hemp, CBD Market

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to provide an advantage to market entry for TGOD. . . . ‘Our team has years of direct hands-on experience in the CBD space,’ TGOD CEO Brian Athaide stated in a news release (http://nnw.fm/Va3UN). ‘We are excited to use this advantage to execute on a fast-moving market expansion strategy.’”

To view the full article, visit: http://nnw.fm/0QMYo

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium, global, organic-cannabis company with operations focused on medical-cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic-hemp, CBD-oil operations in Canada and, through its wholly owned subsidiary HemPoland, distributes premium-hemp CBD oil in the European Union. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe, consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, July 19th, 2019 Uncategorized Comments Off

$YGYI Featured in CannabisNewsWire, CBD Industry’s ‘Sweet Spot’

NEW YORK, July 19, 2019 — via CannabisNewsWire – Youngevity International Inc. (NASDAQ:YGYI) today announces its placement in an editorial published by CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company for private and public entities in the cannabis industry.

To view the full publication, titled, “Smart Companies Finding Sweet Spot in Cannabis Processing, Manufacturing Opportunities,” please visit: http://cnw.fm/OU0aI.

The growth of the cannabis industry has been well touted. Consumer spending in the United States topped $10 billion for the first time last year, and that number is only expected to increase, with numbers projected to reach $23 billion by 2022. Some estimates reach even higher — ranging from $31 billion to an almost incomprehensible $130 billion. With all those big numbers, smart companies are eager to find their place in the industry.

In between growers and sellers lie several potential places for companies with expertise to firmly establish themselves in the burgeoning cannabis space. Savvy companies such as Youngevity International Inc. (NASDAQ:YGYI) (YGYI Profile) recognize the potential payoff of being involved in the back end of the cannabis industry. The company’s wholly owned subsidiary Khrysos Industries Inc. just signed a five-year contract to purchase hemp plant biomass for extraction, end-to-end processing and production of hemp-derived products.

About Youngevity International Inc.

Youngevity International Inc., an emerging conglomerate operating in three distinct business segments including a vertically integrated coffee enterprise, a vertically integrated hemp-based product development enterprise including end-to-end processing, and a direct-selling enterprise that consists of an expanding portfolio of consumer brands developed with its in-house product development team and distributed by traditional and nontraditional channels, including a multi-country, direct-selling network. For more information, visit the company’s website at www.YGYI.com.

About CannabisNewsWire (CNW)

CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information please visit https://www.CannabisNewsWire.com.

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Friday, July 19th, 2019 Uncategorized Comments Off

$INMB Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease

INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An association between inflammation and Alzheimer’s disease has long been established. Until present, however, this link and the way in which it could be used to offer reliable AD treatments have both been overlooked. Numerous inflammatory markers are found in AD patients, and several studies establish a link between chronic inflammation and the development of AD. . . . XPro1595 works by targeting the microglial immune cells of the brain. These cells are activated in many AD patients. They cause neuroinflammation that kills nerve cells and promotes synaptic dysfunction. Combined, these two effects lead to dementia in people with AD.”

To view the full article, visit: http://nnw.fm/lmGO3

About INmune Bio Inc.

INmune Bio is a publicly traded, clinical-stage biotechnology company developing therapies targeting the innate immune system to fight disease. INmune Bio is developing three product platforms: two products that reengineer the patient’s innate immune system’s response to cancer and one product to treat neuroinflammation that is currently focused on Alzheimer’s disease. INKmune is a natural killer (“NK”) cell therapeutic that primes the patient’s NK cells to attack minimal residual disease, the remaining cancer cells that are difficult to detect, which often cause relapse. INB03 inhibits myeloid derived suppressor cells (“MDSC”), which often cause resistance to immunotherapy, such as anti-PD-1 checkpoint inhibitors. XPro1595 targets neuroinflammation, which causes microglial activation and neuronal cell death. INmune Bio’s product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and chronic inflammation. To learn more, please visit www.INmuneBio.com.

NOTE TO INVESTORS: The latest news and updates relating to INMB are available in the company’s newsroom at http://nnw.fm/INMB

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, July 19th, 2019 Uncategorized Comments Off

$GGBXF Featured in CannabisNewsAudio Broadcast on Popularity of ‘Cannabis Beauty’

NEW YORK, July 18, 2019 — via CannabisNewsAudio — Green Growth Brands (CSE:GGB) (OTC:GGBXF) announces the availability of an audio press release titled, “Waves of CBD Beauty Products Filling Shelves of Major Retailers Across the US.”

To hear the CannabisNewsAudio version, visit: http://cnw.fm/sC5as.

To read the full editorial, visit: http://cnw.fm/6vjFQ.

Perhaps the most impactful addition to the CBD sector is the rise of “cannabis beauty.” Analysts at Piper Jaffray believe the cannabis beauty wave could potentially boost the overall CBD market to between $50 billion to $100 billion.

In July, American Eagle agreed to stock the shelves of nearly 500 stores with Green Growth Brands’ (CSE:GGB) (OTC:GGBXF) tailor-made, CBD-infused personal care products. The new line of products will be available as early as October and will be available for purchase online as well.

In late June, fashionable brand Abercrombie & Fitch expanded its partnership with Green Growth Brands to sell Seventh Sense Botanical Therapy products in more than 160 A&F stores. The American Eagle and A&F placements supplemented the string of partnerships Green Growth Brands has secured so far in 2019, which began with a partnership with DSW Inc. to sell Seventh Sense in 96 U.S.-based DSW stores.

About Green Growth Brands Inc.

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+ Source, Green Lily and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the United States, its CBD presence at ShopSeventhSense.com, and in malls across the country and at DSW shoe stores — and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

About CannabisNewsWire (CNW)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Forward-Looking Statements

Corporate Communications:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Thursday, July 18th, 2019 Uncategorized Comments Off

$YGYI Smart Companies Finding Sweet Spot in Cannabis Processing, Manufacturing Opportunities

CannabisNewsWire Editorial Coverage: In between growers and sellers lie several potential places for companies with expertise to firmly establish themselves in the burgeoning cannabis space.

Savvy companies such as Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) recognize the potential payoff of being involved in the back end of the cannabis industry. The company’s wholly owned subsidiary Khrysos Industries Inc. just signed a five-year contract to purchase hemp plant biomass for extraction, end-to-end processing and production of hemp-derived products. Indiva Limited (TSX.V: NDVA) (OTCQX: NDVAF) has successfully received an amended license from Health Canada for three additional grow rooms and three additional processing rooms. Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT) recently announced that its wholly owned subsidiary received a notification letter from Health Canada indicating that all requested license amendments have been approved. Other cannabis companies are making strategic moves in the industry as well. CannaRoyalty Corporation (CSE: OH) (OTCQX: ORHOF) has obtained final approval to move forward with its plan of arrangement with Cresco Labs, which will result in the largest-ever public company acquisition in the U.S. cannabis sector. And KushCo Holdings Inc. (OTCQX: KSHB) has partnered with C.A. Fortune, a leading full-service national consumer products sales and marketing agency, with the intent to grant…

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Thursday, July 18th, 2019 Uncategorized Comments Off

$OGI Brand Innovation Key to Leading in Cannabis-Infused Beverages

As countries around the world begin to lift a nearly century-long prohibition on cannabis, products created with or derived from the cannabis plant are breaking into new markets at an astounding rate. In addition to smoking, vaping, and oil products, customers are choosing to purchase cannabis-infused beverages for both their recreational and wellness applications. This is an under-publicized, but incredibly lucrative slice of the cannabis sector, and companies that market their cannabis-infused beverages the right way, like BevCanna Enterprises Inc. (CSE:BEV), OrganiGram Holdings Inc. (TSXV:OGI) (NASDAQ:OGI), Koios Beverage Corp. (CSE:KBEV) (OTCPK:KBEVF), Sproutly Canada (CSE:SPR) (OTCQB:SRUTF), and HEXO Corp. (TSX:HEXO) (NYSE:HEXO) will be the ones to corner this market just as it begins to mature.Cannabis-infused drinks are already turning considerable profits, causing some of the biggest beverage companies in the world to begin investing in them. The owners of Heineken, Corona, and Coors have already begun making partnerships with a variety of Canadian cannabis corporations. Even Coca-Cola has reportedly been in “serious talks” to explore its own line of pot-infused beverages.

All this industry attention means that the market is expected to grow considerably over the next few years. In February, Zion Market Research projected that worldwide demand for cannabis beverages would grow from $1.6 billion USD in 2018 to $4.46 billion USD by 2025. Zenith Global, a leading food and drinks consultant, reports that by 2024, the market for CBD beverages alone will be worth $1.4 billion USD in the United States. From its 2018 valuation of $89 million USD, that’s an increase of more than 1,500 percent.

Exciting Products Can Capture a Young Market

The opportunity presented by these numbers is not lost on BevCanna Enterprises Inc. (CSE:BEV). Based in British Columbia, the company has access to 100-acres in the Okanagan Valley that is now licensed to cultivate sun-grown hemp. It also has an on-site world-class manufacturing facility with a spring water aquifer and production capacity of 72 million bottles per shift, per year. This allows BevCanna (CSE:BEV) to ensure that its premium in-house brands and white label products are low-cost and high-quality.

BevCanna (CSE:BEV) only began trading on the Canadian Securities Exchange on July 2 and days after its IPO, the company announced that it had earned an Industrial Hemp Cultivation License from Health Canada. Then, on July 8, BevCanna (CSE:BEV) debuted its first brand, Anarchist Mountain Beverages.

Capturing the frontier spirit of BC, the name Anarchist Mountain Beverages represents the unique site of bottling operations on Anarchist Mountain. Product assortments will include drinks, shots, and powdered mixes. These beverages will be THC-dominant and feature distinct botanical flavors meant to evoke the essence of the pacific northwest, including elements like orchard fruit, pine forests, and wildflowers.

In Oct 2019 Health Canada’s regulations for infused products including edibles and beverages will take effect, with product expected to appear within regulated retail channels as early as December. Analysts expect supplies of cannabis-infused products to be tight when they first go on sale. Because of this, the companies that can position themselves as first movers will be able to establish key brand recognition.

Right beside BevCanna (CSE:BEV) in anticipating Canada’s legalization of recreational cannabis consumables is OrganiGram Holdings Inc. (TSXV:OGI) (NASDAQ:OGI). On July 8, OrganiGram announced the development of proprietary technology for the production of liquid and powdered water-soluble cannabinoids. However, the company has yet to announce how or where it will manufacture these beverages.

Already well-positioned, Koios Beverage Corp. (CSE:KBEV) (OTCPK:KBEVF) entered into an exclusive licensing agreement with CanCore Concepts Ltd. through its subsidiary Cannavated Beverage Co. The agreement will see CanCore produce, market, and sell a line of beverages that are both infused with cannabis and offer nootropic supplements from Koios’s functional beverages.

Another agreement leading to innovations in the cannabis drink market is the one signed between Sproutly Canada (CSE:SPR) (OTCQB:SRUTF) and New Brunswick-based Moosehead Breweries Ltd. The brewing company is interested in producing a line of THC beverages that will take effect in roughly five minutes and last up to an hour and a half. While neither company has yet revealed how they will be making these products available, Moosehead’s experience marketing intoxicating drinks will likely give it an advantage.

Similarly, HEXO Corp. (TSX:HEXO) (NYSE:HEXO) formed a joint venture last year with Molson Coors Canada. Together, the two will work towards developing non-alcoholic, cannabis-infused beverages for the Canadian market. Like Sproutly, HEXO can leverage the experience of the alcohol giant to target consumers looking for recreational drinks with industry insight and precision.

Innovative Marketing is Required to Be Both Responsible and Lucrative

When Health Canada announced its regulations for cannabis edibles in June, many industry insiders felt the restrictions were “tight” and “risk-averse.” Companies looking to break into the burgeoning cannabis consumables industry will have to put considerable effort into ensuring that they are compliant. This extends not only to the cultivation and manufacturing side of the business but to the marketing side as well.

It is critical that BevCanna Enterprises Inc. (CSE:BEV) and its contemporaries appeal broadly to consumers while adhering to government regulations. To achieve this balance, BevCanna has signed an exclusive marketing agreement with Dossier Creative, a world-renowned brand design firm. Dossier has already helped establish brands like Mike’s Hard Lemonade, Trace Beverages, Naked Grape, Bodacious, The Little Potato Company, Jackson Triggs, Vega, and many more.

In addition, BevCanna (CSE:BEV) announced on July 16 that it is bringing Dossier’s co-founder and innovation director, Don Chisholm, onto its team. Chisholm will become the company’s Chief Brand and Innovation Manager, a role that will see him help develop beverage concepts, IP, visual designs, marketing and sales materials, digital properties designs, and content messaging.

Other companies like OrganiGram Holdings Inc. (TSXV:OGI) (NASDAQ:OGI) will be marketing its own line of liquid and powdered water-soluble cannabis products in the near future. Koios Beverage Corp. (CSE:KBEV) (OTCPK:KBEVF), through its wholly-owned subsidiary Cannavated Beverage Co. has already partnered with CanCore Concepts Ltd. The Colorado-based CanCore will be marrying the Cannavated nootropic formula into its own well-established line of cannabis beverages.

For its part, Sproutly Canada (CSE:SPR) (OTCQB:SRUTF) signed an agreement with Moosehead Breweries Ltd to create a suite of alcohol-free marijuana beverages that will provide a unique experience for consumers without breaking Health Canada restrictions. Like Sproutly, HEXO Corp. (TSX:HEXO) (NYSE:HEXO) partnered with a major alcohol producer— Molson Coors Canada—to rely on recreational drink industry experience to help break into the newfound market for cannabis drinks.

As cannabis-infused beverages begin to line shelves alongside beer, coffee, and soft drinks, companies like BevCanna that market the uniquely appealing aspects of their products to the new base of consumers – along with established manufacturing infrastructure and assets – will be the ones to capture this soon-to-be sizable market in its earlier days.

For a free research report on BevCanna Enterprises Inc. (CSE:BEV), visit MicroSmallCap.com

Legal Disclaimer/Disclosure: While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. Furthermore, it is certainly possible for errors or omissions to take place regarding the profiled company, in communications, writing and/or editing. Nothing in this publication should be considered as personalized financial advice. We are not licensed under any securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this article is not provided to any individual with a view toward their individual circumstances. Baystreet.ca has been paid a fee of one thousand nine hundred dollars from Native Ads for distribution of this article. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this article as the basis for any investment decision. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing Baystreet.ca, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

Thursday, July 18th, 2019 Uncategorized Comments Off

$LXRP DehydraTECH Consistently Outperforms Industry Standards

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently reported that clinical lab tests conducted with live animals demonstrated that its new, enhanced version of DehydraTECH(TM) can deliver eight times more CBD into the blood and 19 times more CBD into the brain tissue than standard industry formulations (http://nnw.fm/91ZQd). An article discussing the company reads, “LXRP intends to perform more studies on the enhanced DehydraTECH and focus on optimizing implementation regarding product applications for its licensees. . . . In earlier test results, LXRP announced that original or standard DehydraTECH combined with generic nanotech techniques delivers 1,137% more cannabidiol (CBD) into animal brain tissue following oral ingestion than certain existing industry formulations (http://nnw.fm/SU1sL). The tests consisted of oral administration of CBD into 10 male Sprague-Dawley rats.”

To view the full article, visit: http://nnw.fm/81OaC

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. licenses disruptive, patented-delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, July 18th, 2019 Uncategorized Comments Off

$TCAN TransCanna Holdings Inc. Adds Top-Tier Executive to Ranks

TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently named Alan R. Applonie as general manager of its Modesto facility (http://nnw.fm/2kQDG). A recent article discussing the company reads, “The appointment was made after screening of top-tier talent from the industry for a period of six months. Applonie most recently oversaw a major consumer-goods facility that generated approximately $300 million in annual gross revenues. He will be overseeing all of the manufacturing and related activities at the 196,000-square-foot hub, as well as other units being acquired in Stanislaus County. . . . With this one single move, TransCanna has instilled years of experience, knowledge and expertise into the management of the company. Applonie’s forte lies in managing supply-chain operations and processes related to agricultural-based CPG products. He has also been associated with consumer goods giants like Amazon, 7-Eleven, Kroger, Walmart and Starbucks.”

To view the full article, visit: http://nnw.fm/qNc1V

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://nnw.fm/TCAN

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, July 18th, 2019 Uncategorized Comments Off

$PBIO Flagship Barocycler 2320EXTREME Featured at International Conference in China

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was prominently featured at a three-day, internationally-attended scientific conference held at the elite Westlake University in Hangzhou, China. Professor Tiannan Guo, MD., PhD, a well-known protein research scientist, was one of the primary conference organizers. Professor Guo’s Westlake laboratory was named a PBI Center of Excellence in 2017. “Many of the studies on cancer biopsy tissues performed at Westlake and in the laboratories of our collaboration partners rely critically on PBI’s PCT platform to rapidly and reproducibly extract high quality proteins from tumor tissues for analysis by mass spectrometry,” Professor Guo stated in the news release. “It is hoped that such activities will eventually result in the discovery of new biomarkers of disease and possibly even new drug targets.”

To view the full press release, visit: http://nnw.fm/2AsJr

About Pressure BioSciences Inc.

Pressure BioSciences (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, July 18th, 2019 Uncategorized Comments Off

$PBIO Delivers Custom Ultra Sheer Instrument to Ohio State for Food Safety Research

PBIO’s proprietary Ultra Sheer Technology (“UST”) platform can be used to create the higher quality, more nutritious, longer-lasting, chemical-free foods that consumers demand
Recent delivery of a working benchtop UST instrument to Ohio State scientists marks the first major milestone in a nearly $1 million federally funded collaborative study
Separate from the collaboration between PBIO and OSU in the liquid food (primarily dairy) area, PBIO’s UST platform, which has been proven to create high quality, visually clear nanoemulsion mixtures of oil and water, has the potential to play a critical role in pharmaceuticals, cosmetics, and nutraceuticals
The company recently announced its entry into the cannabis marketplace with a major focus in the CBD area; its new UST-based instrument can make CBD oil water-soluble, increasing its absorption and bioavailability

Foodborne illnesses are a costly, common public health problem. Researchers have identified more than 250 foodborne diseases, with 48 million people a year falling ill after consuming contaminated foods or beverages, according to the U.S. Centers for Disease Control and Prevention (http://nnw.fm/Rhd2I). Of those who get sick, 128,000 are hospitalized, and 3,000 die. “Do I have food poisoning?” is a very common expression and one of the first thoughts people express when they worry about whether they’ve been infected by a foodborne infection.

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, has developed a…

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, July 17th, 2019 Uncategorized Comments Off

$INMB XPro1595 May Reduce Risk of Alzheimer’s, Report Suggests

Research indicates that anti-inflammatory medications have the power to prevent the onset and control the symptoms of Alzheimer’s disease
The link between inflammatory processes and Alzheimer’s has long been established; companies like INmune Bio are working to further the research and develop safe and effective drugs based on disrupting this mechanism
INmune Bio has received a $1 million grant from the Alzheimer’s Association to bring its lead drug candidate, XPro1595, to the clinical testing stage

Could tumor necrosis factor-alpha (TNF-α) inhibition be the next big thing in the world of Alzheimer’s disease (AD) treatment? A detailed Washington Post report focuses on research carried out by a Pfizer Inc. (NYSE: PFE) team (http://nnw.fm/3R9va). According to the researchers, one of the company’s rheumatoid arthritis anti-inflammatory drugs appeared to reduce the risk of Alzheimer’s disease development by as much as 64 percent.

Pfizer researchers went through thousands of insurance claims in 2015, reaching the conclusion that the rheumatoid arthritis pharmaceutical had such an effect on AD. Carrying out a…

NOTE TO INVESTORS: The latest news and updates relating to INMB are available in the company’s newsroom at http://nnw.fm/INMB

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, July 17th, 2019 Uncategorized Comments Off

$GGBXF Featured in CannabisNewsWire, Mainstream Retailers Making Room for CBD

NEW YORK, July 17, 2019 — via CannabisNewsWire – Green Growth Brands (CSE:GGB) (OTC:GGBXF) today announces its placement in an editorial published by CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company for private and public entities in the cannabis industry.

To view the full publication, titled “Waves of CBD Beauty Products Filling Shelves of Major Retailers Across the US,” please visit: http://cnw.fm/6vjFQ.

The bond between retailers and CBD producers seems to be growing stronger by the month, ushered forward by bridge builders such as Green Growth Brands (CSE:GGB) (OTC:GGBXF), whose management team’s CVs read like that of a mall directory, including executive-level experience with major brands such as American Eagle Outfitters, Abercrombie & Fitch, Bath & Body Works, Victoria’s Secret, DSW, Luxottica and Virgin Entertainment.

These relationships have already resulted in GGB inking a series of deals with major retailers, most recently with American Eagle Outfitters. Starting in October 2019, the clothing retailer will be carrying GGB’s hemp-derived, CBD-infused personal care products in almost 500 physical stores as well as on the company website. These products — which include lotions, muscle balms and aromatherapy items — were developed exclusively for American Eagle.

About Green Growth Brands Inc.

About CannabisNewsWire (CNW)

CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Forward-Looking Statements

Corporate Communications:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Wednesday, July 17th, 2019 Uncategorized Comments Off

$GGBXF Waves of #CBD Beauty Products Filling Shelves of Major Retailers Across the US

CannabisNewsWire Editorial Coverage: Mainstream retailers across the United States are embracing the growing popularity of the nonpsychoactive cannabinoid, cannabidiol (CBD), making room for CBD products on their prominent shelves.

With the rise of these cannabis beauty products, major stores from luxury retailers Barney’s and Neiman Marcus down to Walgreens, Rite Aid and now Kroger are stocking products from a range of CBD SKU producers, including Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) (GGBXF Profile), Charlotte’s Web Holdings (TSX: CWEB) (OTCQX: CWBHF), CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST), Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) (OGI Profile) and…

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Tuesday, July 16th, 2019 Uncategorized Comments Off

$CNPOF $RIV.V $RIV Releases Q4, FY19 Financial Highlights; Corporate Update

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning released its financial results for the three and twelve months ended March 31, 2019. Audited consolidated financial statements for Canopy Rivers for the twelve months ended March 31, 2019, as well as its full Management’s Discussion and Analysis (the “MD&A”) for the three and twelve months ended March 31, 2019, are available under the company’s SEDAR profile and on the company’s website. “It was a year full of milestones and significant achievements for Canopy Rivers. Anchored by our go public transaction and listing on the TSX Venture Exchange, eight new investments, and landmark transactions for certain portfolio companies, we have strategically positioned ourselves as an accelerator of growth for companies that we believe are situated to be leaders in the cannabis industry,” Canopy Rivers President and CEO Narbe Alexandrian stated in the news release. “We are excited for the future as we continue to discover, evaluate, and invest in ways that expand our footprint into new channels and markets globally, ultimately creating value for our shareholders. With positive global sentiment towards cannabis on the rise, and Canada’s legalization of edibles, extracts, and topicals coming into force in the fall, we are optimistic about the growth potential of the cannabis industry in the coming years.”

To view the full press release, visit: http://nnw.fm/pfF64

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://nnw.fm/CNPOF

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, July 16th, 2019 Uncategorized Comments Off

$INMB Helping to Drive Alzheimer’s Disease Market Growth

Companies like INmune Bio are advancing the development of innovative treatment methods
INmune’s lead drug candidate, XPro1595, works by targeting neuroinflammation, one of the causes of Alzheimer’s
XPro1595 is set to undergo a phase I clinical trial in the summer of 2019 with a goal of measuring traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer’s

The global market for Alzheimer’s disease (AD) treatments is forecast to double in value by 2023, reaching $4.9 billion, according to GlobalData research (http://nnw.fm/e2TV5). The growth rate has been estimated at 10.5 percent for the forecast period.

The increasing prevalence of Alzheimer’s disease, advanced diagnostic capabilities and technological advances are all expected to contribute to the future growth. Companies like…

NOTE TO INVESTORS: The latest news and updates relating to INMB are available in the company’s newsroom at http://nnw.fm/INMB

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, July 16th, 2019 Uncategorized Comments Off

$NUGS Senate Could Hold Hearings on Cannabis Banking Later this Month

The Senate Banking Committee could schedule hearings on bipartisan legislation on cannabis banking in as little as two weeks. This revelation was made by the chairman of that committee, Mike Crapo (R-ID) as he talked to American Banker.

Crapo said that he was looking into the prospect of scheduling a hearing on the matter and added that the hearings will be “relatively soon.”

This statement marks a huge change of heart for the senator from Idaho who is on record saying (in April) that he wouldn’t commit his committee to holding sessions on marijuana banking as long as marijuana is still illegal at the federal level.

Banking industry insiders believe that the committee is likely to have two hearings in the week starting July 22. One hearing will be centered on hearing from the regulators of the banking sector while the second hearing will listen to the other stakeholders on this matter.

A similar bill was passed by the Congressional Banking Services Committee in March and similar language to the contents of the STATES Act was included in the appropriations bill.

While pro-cannabis advocates have been hoping that the STATES Act is put on the schedule for a vote by the entire House before the legislative chamber goes for recess in August, this hasn’t happened as yet. It now seems that a vote on the bill may have to wait until the fall.

Concerns have also been voiced about how the STATES Act would be received once it gets to a Senate that is dominated by Republicans.

Rep. Ed Perlmutter (D-CO), the chief sponsor of the House version of the bill, revealed that lawmakers are currently exploring other ways to generate Republican support for the bill. One of the avenues being explored is including language to the effect that regulators will not prevent payday lenders and gun manufacturers from accessing banking services.

Another avenue that could be used is the inclusion of language that protects the hemp industry so that Republicans don’t look at that the bill as one on just marijuana.

A senate hearing on marijuana business banking would mark another milestone for those who want to see marijuana policy reform. While the STATES Act will not alter the status of marijuana federally, it is a step in the right direction since many advocates see the incremental approach to legalization as a more realistic option when compared to the chances of a standalone bill on legalization passing in both chambers.

Industry watchers believe that the entire cannabis industry, including Cannabis Strategic Ventures Inc. (OTCQB: NUGS) and Youngevity International Inc. (NASDAQ: YGYI), will be waiting with bated breath to hear what comes out from the Senate committee hearings.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Tuesday, July 16th, 2019 Uncategorized Comments Off

$TGODF 10,000 Licenses Issued, California Reflects the Growing Power of Hemp

CannabisNewsWire Editorial Coverage: As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is supporting many of these companies that have cultivation licenses by providing cultivation and extraction equipment. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), one of the biggest companies in the sector, is increasing its growing capacity while helping educate about medicines. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) is leaning into new technology, with new facilities for R&D and processing. The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) (TGODF Profile) has tapped into the demand for organic produce and is now expanding into global CBD market. GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) is developing powerful new medicines, in which hemp could help tackle…

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Tuesday, July 16th, 2019 Uncategorized Comments Off

$OGI Expanding Capacity, CBD Beauty Product Wave Hits Retail

Organigram has distribution in all 10 Canadian provinces and has now received licensing approval from Health Canada for its Phase 4A expansion efforts, which are expected to bring its annual production capacity to 61,000 kg
The company is well-positioned for Canada’s anticipated edibles and derivative legalization, expected in October 2019, with expanding production capacity, R&D and various strategic partnerships
Phase 4 construction is on track for completion by the end of 2019, with an aim of increasing target production capacity to 113,000 kg per year once fully licensed and operational

Organigram Holdings Inc. (NASDAQ: OGI) (TSX.V: OGI) is pursuing an aggressive expansion strategy as Canadian cannabis consumers look forward to the country’s legalization of edibles and other derivatives that could be found on retail shelves as early as mid-December 2019.

Organigram recently announced that it has received Health Canada approval for the licensing of all of its Phase 4A buildout plans for total licensed production capacity of 61,000 kg per year, according to…

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://nnw.fm/OGRMF

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

-also-

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Tuesday, July 16th, 2019 Uncategorized Comments Off

$LXRP Live Investor Presentations Now Available for On-Demand Viewing

NEW YORK, July 15, 2019 – Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the July 11^th life sciences conference are now available for on-demand viewing at VirtualInvestorConferences.com.

REGISTER OR LOGIN NOW AT: https://tinyurl.com/July11VICPR

July 11^th Participating Companies:

Company	Ticker(s)
The Trendlines Group Ltd.	OTCQX: TRNLY \| SGX:42T
Orexo AB	OTCQX: ORXOY \| STO: ORX
NervGen Pharma Corp.	OTCQX: NGENF \| TSX-V: NGEN
Cresco Labs Inc.	OTCQX: CRLBF \| CSE: CL
Menlo Therapeutics, Inc.	NASDAQ: MNLO
Next Green Wave Holdings Inc.	OTCQX: NXGWF \| CSE: NGW
Lexaria Bioscience Corp.	OTCQX: LXRP \| CSE: LXX

To facilitate investor relations scheduling, for more information about the program and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences^SMVirtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

SOURCE Virtual Investor Conferences

View original content: http://www.newswire.ca/en/releases/archive/July2019/15/c9771.html

Media Contact: OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com; Virtual Investor Conferences Contact: John M. Viglotti, SVP Corporate Services, Investor Access, OTC Markets Group, (212) 220-2221, johnv@otcmarkets.comCopyright CNW Group 2019

Monday, July 15th, 2019 Uncategorized Comments Off

$VVCIF Ballot Measure to Legalize Recreational Marijuana in Arkansas

A marijuana education and advocacy group in Arkansas has announced that it plans to file two petitions with the state government so that recreational marijuana can be legalized through a ballot measure. The second petition covers the expungement of marijuana-related convictions.

Drug Policy Education Group (DPEG), the nonprofit planning the petitions, says that they had initially wanted to have both issues (legalization and expungement) in the same initiative. However, their legal advisors recommended that they submit separate petitions since it would be hard for the Attorney General to approve a petition which has a constitutional amendment within another proposed amendment.

Melissa Fults, the Executive Director of DPEG, revealed that they had been planning the petitions for more than a year but they decided to move quickly since the lawmakers seem to be moving towards making it harder for voters to effect changes to the state constitution.

Fults revealed that there was consensus among pro-medical marijuana advocates that the Medical Marijuana Commission (MMC) and the State General Assembly had deliberately delayed the launch of the medical cannabis program after voters approved a constitutional amendment in 2016. Sales started 2.5 years after the constitutional amendment, and sales totaling $2 million had so far been registered.

Fults and other advocates have been trying to see more reforms made to the existing cannabis laws. For example, they tried to expand the list of medical marijuana qualifying conditions to three times its current size but the bill failed to make it beyond committee level during the legislative session that has just ended.

The first petition, named Arkansas Adult Use Cannabis Amendment (AAUCA) seeks to give the state’s finance department, through its Alcohol and Beverage Control Division, permission to draft regulations for the recreational marijuana program (cultivation, manufacturing, testing and sales). Under the proposal, adults who are at least 21 years old will be allowed to purchase recreational marijuana in addition to having a maximum of six seedlings and six mature plants for their own use.

The second ballot petition, named the Arkansas Marijuana Expungement Amendment (AMEA), seeks to allow people who were convicted for possessing up to 16 ounces of cannabis to petition a court (which will be set up for this purpose) to be released from prison, have the conviction expunged or request for the restoration of their rights.

Under Arkansas law, any proposed petition for the passing of a new law requires signatures of at least 8 percent of the voters who participated in the most recent elections. A petition for a constitutional amendment requires 10 percent voter support to be approved for inclusion on the ballot.

The nonprofit and its supporters therefore have their work cut out if their petition is to see the light of day. Pundits think that the entire cannabis industry, including participants like VPR Brands LP (OTC: VPRB) and VIVO Cannabis, Inc. (TSX.V: VIVO) (OTCQX: VVCIF), will be rooting for the success of the initiatives since adult Arkansans will be able to enjoy the numerous benefits of the adult-use marijuana industry, such as employment.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Monday, July 15th, 2019 Uncategorized Comments Off

$TGODF Millennials Investing in a Green Future: Cannabis to Solar

Point Roberts, WA and Delta, BC – July 15, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering cannabis, hemp and solar stocks releases a sector snapshot reporting on green investing trends from renewable energy to cannabis and how millennial investors are driving this movement.

TD Ameritrade’s recent trading data reflected this green investing trend; “Millennials with TD Ameritrade accounts favored buying Tesla, Canopy Growth, Beyond Meat, Uber and Nvidia in June, according to new research from the brokerage platform. What’s interesting – and perhaps alarming to the hardcore over 40-year-old investor – is that all of these companies except for Nvidia are solidly unprofitable. Moreover, it’s wildly unclear when the likes of Tesla, Canopy Growth, Beyond Meat and Uber will turn sustainably profitable.”

This speaks to the many uptrends we’ve seen in solar and renewable energy stocks, along with cannabis and wellness companies as younger investors seem to focus more heavily on concept and environmentalism first, and profitability second. But they may be seeing a greener future as they continue to bet on the sector.

According to a report on the global Solar Panel Market from Zion Market Research, the solar market accounted for USD 30.8 billion in 2016 and is expected to reach USD 57.3 billion by 2022, growing at a CAGR of 10.9% between 2017 and 2022.

The report states, “the Global Solar Panel market is expected to witness positive growth within the forecast period on account of increasing government incentives for the adoption of renewable energy alternatives for power generation. A solar panel uses solar energy to cleanly and efficiently produce electricity. For many years solar was considered as the main pillar of a future renewable energy based system. Demand for a solar panel is increasing prominently all over the world.”

SinglePoint Inc. (OTC: SING), a technology and acquisition company that provides mobile payments, ancillary cannabis services and solar in the United States has been betting on both aspects of this green strategy to ensure a synergistic future. For the hemp component, the company recently announced signing a large contract to supply more than 275,000 pounds of premium hemp flower over a period of 15 months, while the company’s solar subsidiary, Direct Solar has been developing a commercial solar lending solution to serve customers that own and/or manage commercial properties.

Direct Solar will be one of the first companies to offer this type of lending solution and is expected to launch in the next four to six weeks.

“Currently there are a lot of residential lending solutions as well as large scale lending for solar farms and high megawatt projects. We have yet to find a solution that will finance projects in the small to medium commercial space. Our financing solution will provide these customers with quick funding turn around and require no personal guarantees. We believe there is enough projects for us to turn $100 Million dollars in lending over the next 9-12 months,” states Pablo Diaz, Founder and CEO of Direct Solar.

“This is a massive opportunity to fill a huge gap in the market. There has not been a solution we’ve found like ours simply because the current model means you are either a lender or installer. Direct Solar being one of the only solar brokers in the market means we can work with the customer to find the right installer and the right lender. Matching these two together is a win-win for everyone involved,” states Brian Odle, National Finance Director, Direct Solar.

Coming off of a major month (May 15, 2019 – June 15, 2019), Direct Solar closed $1,709,460 in solar installs. This revenue should generate approximately $803,769 in gross and $361,541 in net. Additionally, the company added three new major service areas with a fourth on the way. This has all been residential driven. The addition of the commercial solar opportunity should dramatically increase the quick growth the company has already been experiencing.

These numbers quickly put Direct Solar on the path to profitability from a cash flow standpoint. Management from SinglePoint and Direct Solar are very excited to see the continued growth of the solar business through multiple avenues including commercial.

Direct Solar, also recently announced that the company has signed on to become the exclusive solar marketing partner to support the various fall sports programs for 47 Texas schools across Dallas/Fort Worth, Houston, Austin and Waco. Between August 1st and December 31st, 2019, any solar systems that are sold within these school districts will receive a $250 donation to the Fall Sports Booster Program at the school.

“We appreciate the support we have received from Texas. We wanted to find a way to give back to the communities that we have been doing business in and felt what better way to show that support by donating to the Fall Sports Booster Programs,” states Allen Kruse, Marketing Director of Direct Solar.

Canadian Solar Inc. (NASDAQ: CSIQ), one of the world’s largest solar power companies, recently announced that its wholly owned subsidiary Recurrent Energy, LLC has signed a 15-year power purchase agreement with Anheuser-Busch, the beverage company who late last year signed an agreement with Tilray, for 310 MWp/222 MWac of electricity from its Maplewood solar project.

This landmark contract is the seventh largest commercial and industrial power purchase agreement for solar energy signed in the entire world to date, according to data supplied by Bloomberg New Energy Finance. The PPA, which marks the early achievement of Anheuser-Busch’s 2025 Renewable Electricity goal in the United States, also represents the US beverage industry’s largest single purchase of solar energy.

“The signing of this power purchase agreement with Anheuser-Busch, the US beer industry leader, demonstrates Canadian Solar’s ability to meet the needs of a diverse array of corporate customers. We’re honored to supply affordable clean energy to a C&I customer base spanning the sectors of academia, transportation, traditional energy, and now food and beverages,” said Dr. Shawn Qu, Chairman at Canadian Solar. “Looking at publicly announced deals, we are proud to be the leading solar developer in the Texas market, with over 1.3 gigawatts of signed electricity contracts for energy generated within ERCOT’s service territory.”

The Maplewood solar project, located in Pecos County in the Permian Basin of West Texas, will power the equivalent of 55,000 homes with clean electricity when it begins operations by 2021. Canadian Solar’s high efficiency poly modules are likely to be used for the project.

“We take immense pride in being good stewards of the environment and are excited to announce that by 2021 our entire portfolio of beers will be brewed by using 100 percent renewable electricity from solar and wind power,” said Ingrid De Ryck, Vice President, Procurement and Sustainability at Anheuser-Busch. “Through our new partnership with Recurrent Energy, we will be able to complete one of our 2025 U.S. sustainability goals four years ahead of schedule.”

Some companies like The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), have built their whole company around “green initiatives” with their main focus being on recyclable packaging, LED efficient lighting and hybrid facilities which allow for absorption of natural sunlight, environmental advocacy as well as organic certification. The company recently announced that its flagship Valleyfield, QC facility has received its organic certification from Pro-Cert, an internationally recognized leader in organic certification.

Once completed, TGOD’s Valleyfield facility is going to be the world’s largest organic cannabis facility at over 1.3 million square feet. This Pro-Cert recognition adds another certification to the Company’s portfolio, in addition to TGOD’s already certified organic growing facilities in Canada and Europe and shows TGOD’s commitment to cement its position as the leading organic cannabis brand globally.

“It’s exciting to reach new milestones as we begin commercial production. Growing certified organic cannabis at scale is a highly complex process which has taken time, great care and extensive research to refine. Each of our facilities goes through a robust certification process, in line with the high standards we have set, ensuring operational excellence at all stages,” commented Brian Athaide, CEO of TGOD. “The proprietary methods our team has developed leverage the benefits of growing in living soil and guarantees the organic integrity of the products throughout the entire production chain.”

Pro-Cert’s certification programs are ISO 17065 compliant and accredited, providing global recognition and international access to the products and brands they certify. The certification process includes validation of inputs, production methods and preparation procedures according to Canadian organic product regulation.

While solar may be the future for many, there is also some movement in outdoor operations to reduce energy needs as 48North Cannabis Corp. (TSXV: NRTH) (OTC: NCNNF) announced that it has completed the planting of its first outdoor cannabis crop at its Good:Farm, Canada’s largest outdoor organic cannabis cultivation facility (3.7 million sq. ft. of cultivation space) in Brant County, Ont.

48North has successfully planted more than 250,000 cannabis seeds at Good:Farm. At the farm, 48North has planted 10 unique cultivars proven to be successfully grown outdoors; both high-THC and high-CBD strains were selected for planting. The Company expects two harvests annually at the Good:Farm. The first harvest is planned for late-August and will be exclusively the Company’s auto-flowering strains; the second harvest, of photoperiod plants is planned for mid-October.

Good:Farm, Canada’s first and largest outdoor organic cannabis facility has the potential capacity to yield more than 40,000 kg of dried cannabis, at what 48North expects to be the lowest cost per gram in the country.

“Planting nearly 100 acres of organic cannabis outdoors was a significant accomplishment for the organization, relying on both established agricultural practices and innovative cannabis production techniques. Our team of expert farmers and growers ensured this ground-breaking task was a success,” said Jeannette VanderMarel, co-CEO of 48North.

Good:Farm has a number of strategic advantages, including ultra-low-cost cannabis as well as environment-friendly and energy-efficient production. In addition, the farm’s production will help address the current national shortage of recreational cannabis.

There are a myriad of factors driving millennial investors towards a ‘greener outlook’, from climate change, rising energy demands, the cost of plastics and investor awareness, but the main element seems to really be investing in a better future, even at the risk of short term profitability.

“They are buying what they know – but they should research these companies,” JJ Kinahan, Chief Market Strategist at TD Ameritrade said on Yahoo Finance’s ‘The First Trade‘ which shows the disconnect between the past 30 years of investing and the future of investing. While previous styles of investing showed research being heavily based only on financials and profitability first, the big picture now is just as much a priority, as companies like Tesla and Canopy Growth have shown. For Millennials, it’s their future and they invest in what they spend on, which is the mantra of one of the best loved investors in our history, Warren Buffett.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com – News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring SING is a paid for service on Investorideas.com (two thousand) . More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411

Monday, July 15th, 2019 Uncategorized Comments Off

$OGI Reports Q3 Fiscal 2019 Results, Hosts Earnings Call

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its financial results for its fiscal third quarter ended May 31, 2019. “We continued to report strong sales in our third quarter and now have distribution in all ten provinces,” Organigram CEO Greg Engel said in the news release. “In our fiscal year to date, we have generated strong operating and financial results, placing us among the leaders in the Canadian industry. While we saw a temporary reduction in yield per plant in Q3 due to temporary changes in growing protocols, not only have our yields returned to historical levels, but we have seen a meaningful increase in average cannabinoid levels in harvests to date in Q4.”

The company held a conference call to discuss its Q3 2019 earnings earlier today. Interested parties may access a replay of the call by visiting http://nnw.fm/rm1KP.

To view the full press releases, visit http://nnw.fm/TLap2 and http://nnw.fm/1pGI2

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange and NASDAQ Global Select listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://nnw.fm/OGRMF

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, July 15th, 2019 Uncategorized Comments Off

$TGODF Debuts Global Strategic Hemp Division, Organic Certification

TGOD is expanding into the global organic-hemp CBD market with its Global Strategic Hemp Division; the global CBD market is forecast to reach $22 billion in three years
The company’s flagship Quebec facility received organic certification from Pro-Cert; the site is slated to reach more than 1.3 million square feet
TGOD plans to enter the U.S. hemp-CBD beverage market through existing partnerships

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is entering the global hemp-CBD market by debuting its Global Strategic Hemp Division. The move will leverage the company’s expertise in the European hemp-CBD market across its established network of international partners (http://nnw.fm/Va3UN).

TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in…

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, July 12th, 2019 Uncategorized Comments Off

$GGBXF Announces Agreement with American Eagle to Sell CBD-Infused Personal Care Products

American Eagle collaboration connects Green Growth Brands with leading global specialty retailer

COLUMBUS, OH, July 11, 2019 – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB) today announced it has received a purchase order from American Eagle Outfitters, Inc. (NYSE: AEO) through which it will sell hemp-derived cannabidiol (CBD) infused personal care products in nearly 500 of its American Eagle (AE) stores and online.

The purchase order represents GGB’s third major wholesale agreement since the passage of the Agriculture Act of 2018 in December 2018 (the 2018 Farm Bill).

The products, which were exclusively developed for American Eagle, include a wide assortment of CBD-infused personal care items such as lotions, muscle balms, and aromatherapy. Sales of the product are expected to begin in October 2019.

“We are very pleased to be partnering with American Eagle, a leader in the specialty retail space,” said Green Growth Brands CEO, Peter Horvath. “GGB provided the expertise necessary to develop the product formulations and packaging to create a really special line of products.”

All Green Growth Brands CBD products are sourced from U.S.-based, licensed hemp processors and comply with the 2018 Farm Bill. GGB sells and distributes topical CBD products only in jurisdictions that permit such sale.

About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The Company also has a licensing agreement with the Greg Norman™ Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S., its CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. Learn more about our vision at GreenGrowthBrands.com.

About American Eagle Outfitters, Inc.
American Eagle Outfitters, Inc. (NYSE: AEO) is a leading global specialty retailer offering high-quality, on-trend clothing, accessories and personal care products at affordable prices under its American Eagle® and Aerie® brands. The company operates more than 1,000 stores in the United States, Canada, Mexico and Hong Kong, and ships to 81 countries worldwide through its websites. American Eagle and Aerie merchandise also is available at more than 200 international locations operated by licensees in 24 countries. For more information, please visit www.aeo-inc.com.

Cautionary Statements:

Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies, including with respect to its retail shop strategy; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018 which is available on the Company’s issuer profile on SEDAR.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release, including without limitation, the expansion of GGB’s Seventh Sense brand, the expected access to new customers in premier retail locations and the expected opening date of the first GGB shop, is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act“), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Thursday, July 11th, 2019 Uncategorized Comments Off

$OGI Toxic, Low-Quality CBD Products Putting Consumers at Risk

FN Media Group Presents Potstocknews.com Market Commentary

New York, NY – July 11, 2019 – When the United Kingdom’s National Health Service (NHS) made cannabidiols (CBD) legal for medical use in November 2018, the health and wellness applications put in place for the benefit of British consumers seemed nearly boundless. With the rapid growth of the CBD product market, it’s becoming more and more important that consumers avoid poor quality products from unregulated, and often unreputable, sources. This means that trusted industry producers such as StillCanna (CSE:STIL) (OTCPK:SCNNF), OrganiGram Holdings (TSXV:OGI) (NASDAQ:OGI), Canopy Growth Corp (TSX: WEED) (NYSE: CGC), Aleafia Health (TSX:ALEF) (OTCQX:ALEAF), and The Green Organic Dutchman Holdings (TSX:TGOD) (OTCQX:TGODF) are set to be forerunners in the market.

Recent reports of low-quality CBD merchandise offering little to no medicinal benefits and containing harmful pesticides have dominated headlines across the UK. The cannabis for these products is typically grown in Northern China, where it absorbs “airborne pollutants and smog-like black dust” before being processed and shipped into the European market. As the UK currently relies on imports for nearly all of its CBD needs—bringing in more CBD from China than anywhere else—British customers are currently at risk of consuming low-quality, toxic CBD products if they aren’t careful about which company they buy from.

StillCanna (CSE:STIL.CN) (OTCPK:SCNNF) CEO Jason Dussault considers these low-quality products to be part of a “wild west” consumer market, wherein customers “sometimes end up buying products that contain such little CBD they have no meaningful therapeutic effect.”

“People are being cheated at the expense of their health and wellbeing,” he said. “Consumers are at risk due to the lack of transparency as to the origin of many questionable CBD products.”

Dussault goes on to say that there simply are not sufficient quality controls placed on CBD-derived products to guarantee the public’s safety.

Quality Products Come from Smart Relationships

StillCanna (STIL.CN-SCNNF) is currently making preparations to begin harvesting its proprietary hemp strain from more than 3706 acres in Poland with legacy hemp production experts Olimax that they recently acquired . That strain has an assured CBD consistency of 7+%, and StillCanna controls its product from “seed to shelf,” so there’s no risk of hemp contamination like there is from other, less trustworthy sources.

OrganiGram Holdings (TSX-V:OGI) (NASDAQ:OGI) is another business that’s putting every effort into ensuring that it delivers only top-notch CBD-derived products. The company recently closed a deal with Eviana Health Corporation, a Serbian-based creator of organic CBD from “natural hemp strains of cannabis sativa.” Because Eviana is a vertically-integrated company that sees its CBD through all stages of production, they can guarantee its quality.

For CBD customers looking to ensure they are buying quality products, it’s usually a safe bet to go with the biggest name in the industry. Canopy Growth Corp (TSX: WEED) (NYSE: CGC), Canada’s largest cannabis corporation, has been expanding into Europe just as consumers are in dire need of a trusted brand. Last year it partnered with Beckley Canopy Therapeutics, a drug research firm from the UK, to bring its medicinal products to Britain. Just this May, Canopy acquired Germany’s C3 Cannabinoid Compound Co. in order to become the leading pharmaceutical option in the European CBD market.

Toronto-based Aleafia Health (TSX:ALEF) (OTCQX:ALEAF) recently received a permit from Health Canada to export its medicinal cannabis to Australia, marking its first international product sale. The company’s chairman, Julian Fantino, says this is just the beginning for its international expansion. Additionally, Aleafia will be bringing its commercially-proven CBD oils to the German market through a joint-venture with Acnos Pharma GmbH. With a population of 82 million, Germany—the second most populated country in Europe—promises to become a major destination for cannabidiol producers. Just last year, a Bank of Montreal report projected that the nation’s medical cannabis market will reach revenues of $5 billion in 2025.

Also getting in on the German market is The Green Organic Dutchman Holdings (TSX:TGOD) (OTCQX:TGODF) whose subsidiary, HemPoland, entered into an agreement with Mediakos to distribute its premium hemp CBD brand to German pharmacies. Commenting on the deal, Nikolas Primbas, CEO of Mediakos, said that TGOD’s organic certification for its brand CannabiGold will be “an important point of differentiation” from other producers, which will “resonate with German consumers.”

If Germany experiences the same deluge of low-grade CBD products that UK consumers are currently dealing with, this will no doubt prove true.

More Growth in the Industry Means More Regulation Is Needed

The assurance of high-quality cultivation is more important for CBD than almost any other crop, as the hemp plant is famous for its bioaccumulation. This means that it sucks up a ton of chemicals from both the soil and the air, which—if producers aren’t extremely careful—leads to a contaminated, low-quality, potentially dangerous product.

StillCanna (STIL-SCNNF) and its contemporaries are going to be taking advantage of their ability to stock Grade-A CBD on the shelves of Europe and North America by establishing themselves as brands that consumers can trust. Together, they’ll be producing high-quality, high-margin CBD oils, capsules, and sprays, as well as topical creams, pharmaceuticals, nutraceuticals, and all kinds of other health products. This will put them in control of the CBD market, which the Brightfield Group estimates will become a $22 billion sector in just three years.

As more data like this becomes available, StillCanna CEO Jason Dussault’s warning about the lack of quality controls on CBD-derived products seems even more prescient. Just as the UK government has yet to take action regulating the wave of substandard CBD products coming into the country from China, the Food and Drug Administration does not closely monitor the CBD market in the US, leading to an epidemic of products being mislabelled.

According to a 2017 study of 84 CBD extract products, taken from 31 different companies, the Journal of the American Medical Association found that 22 products contained less CBD than was advertised on the label. Essentially, this means that any claims of medicinal properties offered by those 22 products could not be considered reliable. A further 36 products contained more than labeled, which is not as considerable a concern, but can potentially still lead to users becoming unwittingly intoxicated.

These are shocking figures, especially considering that 7% of Americans are now taking CBD in some form, a number that could be as high as 10% by 2025. If quality controls aren’t soon established to help customers differentiate trustworthy producers from untrustworthy ones, tens of thousands of people could be cheated out of the medicinal benefits that they pay for when they purchase CBD.

Consumers Need to Learn About the Right Brands to Buy From

The old mantra—location, location, location—is as true for cultivators and manufacturers of CBD-derived products as it is for anyone else. If a company is growing its hemp in a place with a lot of pollution, or a place where growers are using pesticides on their crops, those chemicals will be passed directly to the consumer.

StillCanna (STIL.CN-SCNNF) CEO Jason Dussault helpfully points consumers towards requesting third-party lab results for the products they buy, so as to ensure they aren’t putting toxins into their bodies. Studying these independent reports allows buyers to get a first-hand understanding of which products offer genuine medicine benefits, and which products simply don’t hold up.

“There’s no putting the genie back in the bottle now,” said Dussault. “Patients are increasingly using CBD oils freely for both medically documented ailments and self-diagnosed health issues. So too is anyone who just wants to make CBD a key ingredient for a healthy, holistic lifestyle.”

Other partnerships yielding dependable hemp-derived products include OrganiGram Holdings’ (TSXV:OGI) (NASDAQ:OGI) deal with Serbian-based Eviana, which will allow OrganiGram to feed Europe’s demand for high-grade CBD. Also targeting Europe is Canopy Growth, who burst onto the scene in Britain and Germany to provide top of the line medicinal products.

Aleafia Health (TSX:ALEF) (OTCQX:ALEAF) is expanding into both Australia and Germany, the former via its own exports and the latter through a joint venture with Acnos Pharma GmbH. It’s not the only one taking advantage of the increasingly hungry German market, as The Green Organic Dutchman Holdings (TSX:TGOD) (OTCQX:TGODF) is teaming with Mediakos to place its CBD brand CannabiGold in pharmacies Germany-wide.

As toxic CBD pours from China into Europe, and especially into the UK, these companies will be able to alleviate consumer demand for high-quality CBD products.

For a free research report on StillCanna (CSE:STIL) (OTCPK:SCNNF), visit www.potstocknews.com

Disclaimer: Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of StillCanna Inc.

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PSN and FNM undertake no obligation to update such statements.

Media Contact:

FN Media Group, LLC

info@financialnewsmedia.com

+1(561)325-8757

Thursday, July 11th, 2019 Uncategorized Comments Off

$LXRP DehydraTECH to be Leveraged Through CBD License Agreement with Universal Hemp

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to Universal Hemp LLC. Under the agreement, Universal Hemp, a B2B manufacturer of high-performing hemp-derived bulk ingredients to the consumer packaged goods and nutraceutical industries, will utilize the technology in many CBD-based food ingredients to be produced and sold across the U.S. immediately, as well as in Canada when regulations permit. “We are very excited about signing this licensing agreement with Lexaria Bioscience to bring to market Lexaria’s highly effective delivery system which makes cannabidiol or hemp-derived CBD readily available in the human body,” Universal Hemp CEO and Founder Chad Kahunahana said in the news release. “Lexaria’s unique technology was developed over many years for specified applications and is now, for the first time, being applied to CBD at scale and available for general use. We anticipate our SuperBio Infusion line of ingredients will become the industry leader for CBD-infused health and beauty, food and beverage, wellness, athletic and other products where maximum performance is vital. In terms of bioavailability, shelf stability and taste this is the best performing technology in the market, hands down. Our corporate customers cannot wait to put our water-soluble solution into their products!”

To view the full press release, visit: http://nnw.fm/Ju1bm

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. licenses disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, July 11th, 2019 Uncategorized Comments Off

$TGODF Tech Companies Transforming The Cannabis Industry

What’s the genius of Amazon? Simple: control of information.Jeff Bezos turned a little online book store into one of the world’s most valuable corporate behemoths by applying technological solutions to complex problems—creating a model mirrored around the world.

Now, a little-known company is trying to duplicate that feat.

TruTrace Technologies (CSE:TTT; OTC:TTTSF) is helping other companies “Amazonify” their businesses— creating a niche in the tech world that has yet to be filled.

In other words, it has no competitors yet.

As any retail firm knows, distribution is essential—it can be the biggest source of additional costs and the perfect place to improve efficiency.

Inefficiency can be a killer—a study from 2012 showed that distribution centers lose 3000 hours a year to unproductive workflow.

Lack of control over information costs even more—large businesses lost $47 million per year to inefficiencies in data transfer.

For any business to compete with companies like Amazon it all comes down to distribution—finding the best ways to pair products and markets.

But few businesses have the resources–the talent, technology, and budget–to compete with Amazon.

That’s where TruTrace Technologies comes in.

The company has developed a unique platform to help companies cut costs, streamline marketing and distribution procedures, and eliminate inefficiency in the supply chain.

It’s all about finding the best tech to fit the problem—and TruTrace Technologies (CSE:TTT; OTC:TTTSF) has built a sturdy platform that covers an entire industry’s supply chain, from top to bottom.

Plus, the company’s working in an exciting, rapidly growing new industry—cannabis.

Cannabis produced $6 billion in deal values between 2015 and 2018.

Estimates peg the legal cannabis market at $66 billion by 2025.

But in reality, this tech could be applied to much bigger markets.

TruTrace Technologies (CSE:TTT; OTC:TTTSF) is breaking into cannabis, but it’s got the potential to take on much bigger markets—including retail groceries, which is currently dominated by big supermarket chains like Kroger Company ($105 billion) and H.E.B. ($21 billion).

Right now, it’s signed a new initiative with one of the biggest drug distributors in Canada—with more than 1200 brick-and-mortar stores.

The genius of TruTrace is simple—it’s taking tech solutions to the problems in supply chain.

And where other cannabis plays have focused on production—which firms have the most product, the lowest prices, the biggest chunk of market—TruTrace hopes to make a splash by tackling the issues surrounding the emergence of a new market—one that could be worth billions of dollars.

Why look at TruTrace? Here are a few reasons.

#1 From Top to Bottom

TruTrace doesn’t deal in products—it deals in information.

First, there’s the company’s indexing side:

TruTrace Technologies (CSE:TTT; OTC:TTTSF) has built an incredible platform, allowing firms and users throughout the supply chain to search through a vast database.

The indexing feature, which works through the company’s StrainSecure™ platform, allows any user to track a product from its origins to its destination—from development to production to transportation to retail.

This makes tracking the quality of products far easier. It also helps producers protect their IP—make sure no one else is duplicating their methods.

And there’s real demand for TruTrace’s services in the cannabis sector, where control of information is key.

A lot of it comes down to regulation.

Right now, every jurisdiction manages cannabis a little differently. The legal market is tightly regulated.

In California, for instance, there’s the California Cannabis Portal—a system for tracking changes in regulatory patterns that could affect California’s pot market—which will be worth $5 billion by 2020.

It’s no secret that companies and customers love this kind of service—it makes managing risks much easier, it protects the IP of different strains, and it makes sure there’s a leveled playing field, cutting out the black market.

But TruTrace is going one step further…

#2 The Power of the Blockchain

A lot of the news around blockchain two years ago was hype connected to the Bitcoin bubble—but that doesn’t mean there isn’t an immense opportunity in using blockchain technology.

There are at least fifty industries blockchain could change—and TruTrace (CSE:TTT; OTC:TTTSF) is getting a head-start.

In 2018, the company created an elegant software platform for tracking the origins and quality of different cannabis strains.

Known as Blockstrain, the system has now been taken to the next level.

TruTrace’s new and improved platform, StrainSecure™, uses sophisticated security protocols to collate and manage a vast store of cannabis data—from strain info to regulatory measures to consumer protection.

StrainSecure™ uses blockchain technology —a system for managing supply chains and cutting down on inefficiencies by allowing information to flow more freely through a network.

StrainSecure™ certifies and verifies all the information it collects, and protects it from tampering. The platform also serves regulators and customers by offering “genome to sale” breakdowns of every cannabis strain.

This protects IP while offering authorities and customers the chance to see exactly where each product originates, and what it can do.

It’s a “plug in and play” system, allowing users and firms to join the chain, which uses a linked network of users to ensure security of information, harnessing the computing power of every member to improve the strength of the system.

But that’s not all.

#3 Total Verification, Total Distribution

The StrainSecure platform provides all the information necessary for total verification of products passing through the supply chain.

That’s important for producers who want to protect their IP—particularly in the cannabis world where tracking a product’s origin point is crucially important to carving out a market share and warding off copy-cats.

StrainSecure offers visibility of key information—where each strain was developed, what each one does, possible uses, etc.—but also offers total transparency allowing for total verification.

But the StrainSecure formula also works to cut down the costs of distribution.

All retailers know that slow or inefficient distribution can cost big time—one study estimated inefficiencies could cost distributors $47 million per year in lost revenue.

Inefficiency can result in thousands of lost hours—but TruTrace is hoping to change that.

The company deploys the StrainSecure platforms for companies marketing CBD and other cannabis-adjacent medical products. The platform validates and verifies each company’s product, allowing the companies to match their products with needs all over the markets.

So total verification works hand-in-hand with total distribution.

By working through the StrainSecure platform, each company can verify their product passes through each stage of the supply chain. The service offers transparency and assurance for all who use it—improving trust within the cannabis industry and allowing producers to cut way down on distribution costs.

#4 Expand, Expand, Expand

This tech—the StrainSecure service—is LIVE.

TruTrace (CSE:TTT; OTC:TTTSF) has hit the ground running, and new revenues and partners could be just around the corner.

TruTrace’s different applications gives it multiple revenue streams—from exposure to the medical cannabis industry to helping companies throughout the cannabis supply chain connect with one another.

And there’s already an expansion plan in place.

First, TruTrace plans to cement its place in Canada, where cannabis is fully legal. Through StrainSecure™, the company hopes to construct a sales pipeline for cannabis products to major distributors.

From there, it hopes to move onward to the United States, where cannabis is regulated in more than a dozen states.

In California and Washington DC, where cannabis is decriminalized, TruTrace will target major distributors of CBD and cannabis products—including Walgreens and CVS; each reports more than $100 billion in sales per year.

TruTrace Technologies has its sights set on a world beyond cannabis—bringing its StrainSecure™ tech to markets adjacent to cannabis.

#5 Grow Baby, Grow

Where is TruTrace at right now?

Well, the company is flying way under the radar.

But buzz is starting to build.

StrainSecure™ has plans for expansion in 2019 and 2020.

And the company has just secured a huge opportunity.

TruTrace Technologies (CSE:TTT; OTC:TTTSF) stock jumped on the news that it had signed a deal with Shoppers Drug Mart, a major pharmacy chain in Canada. The company has 1300 stores throughout Canada and is a major name in pharmaceuticals.

This expansion is huge—it gives TruTrace a stable customer in a major market, and solidifies the company’s move away from cannabis into the retail game, with groceries and other major markets coming into view.

“This is a game-changing milestone that partners us with the most recognizable pharmaceutical brand in Canada,” said TruTrace Technologies CEO Robert Galarza.

And with the Shoppers Drug Mart deal in place, a lot more business could be just around the corner.

The stock has been stagnant, but catalysts could be coming—once the company expands access to StrainSecure™ and continues to grow the revenue stream.

TruTrace is sitting on ideas which could make a huge difference in a market that has only just begun its meteoric growth. And its tech—harnessing the power of the blockchain—has applications far beyond TruTrace’s current, relatively narrow base.

Things can only get better from here. Expect the price to potential jump even higher as the deal with Shoppes Drug Mart solidifies—perhaps from $0.20 to $0.30-35 and beyond.

Investors should take note.

Other companies looking to get a leg up in the cannabis race:

Namaste Technologies Inc (OTCMKTS: NXTTF) (TSX.V: N)

Through its subsidiaries, Namaste operates as a retailer of a variety of marijuana products, including vaporizers and other smoking accessories. The company sells its goods through e-commerce sites operating in 26 countries.

In addition to its accessory business, Namaste also engages in product development and the distribution of medical cannabis products in Canada.

Recently, Namaste, through its subsidiary Canmart Inc., entered into a supply agreement with Agra Flora to purchase and distribute up to 10% of Agra Flora’s massive Delta Greenhouse Complex at a price of $4 per gram.

The Green Organic Dutchman (OTCMKTS: TGODF) (TSX: TGOD)

The Green Organic Dutchman is primarily a research and development company focusing on cannabinoid-based products. Most of its products are dried organic cannabis, oils and edibles, but it also is involved in breeding plants to create new strains and distributing seeds for medical applications.

Recently, the Canada-based Dutchman announced a pivotal distribution partnership with HelloMD, a leading online medicinal cannabis company. The Dutchman will begin selling its premium organic product to HelloMD in late January for online distribution.

Andrew Pollock, Vice President of Marketing at the Dutchman, explained, “Patients deserve premium organic cannabis and through the partnership with HelloMD, we are pleased to provide increased access to TGOD’s product lines with the highest level of customer service and functionality to our patients.”

Molson Coors (NYSE: TAP) (TSX: TPX-A)

Molson Coors is an iconic multi-national beer company, with brands that are recognizable across the United States and Canada. Besides just its Molson and Coors lines, the company has also ventured into more niche beverages to take advantage of the growing craft beer market, buying up brands like Leinenkugel’s and Blue Moon.

Not to be left behind in the marijuana boom, Molson Coors is also developing a line of non-alcoholic cannabis-based beverages with its partner, the Hydropothecary Corporation.

Molson Coors Canada president and CEO Frederic Landtmeters noted, “While we remain a beer business at our core, we are excited to create a separate new venture with a trusted partner that will be a market leader in offering Canadian consumers new experiences with quality, reliable and consistent non-alcoholic, cannabis-infused beverages.”

Aurora Cannabis (NYSE:ACB) (TSX:ACB)

Aurora Cannabis is one of the biggest names in the burgeoning marijuana sector. With a market cap over $14 billion, Aurora has carved out its position as a leader in the industry. And the company is still making moves.

Recently, Aurora sealed a supply deal with Mexico’s Farmacias Magistrales SA, the country’s first and, for now, at least, only federally licensed importer of raw materials containing THC.

In an announcement from Aurora, the company stated that the deal “firmly establishes Aurora’s first-mover advantage in one of the world’s most populous countries, where more than 130 million people will have federally legal access to a range of Aurora’s non-flower medical cannabis products containing THC.”

Cronos Group (NASDAQ: CRON) (TSX: CRON)

Following its October slump, Cronos Group has seen a surge in trading volume, with a renewed investor interest in the company thanks to rumors surrounding the company’s discussions with tobacco giant Altria.

The Canadian firm, though primarily an equity investor, has made some major moves in recent years, wheeling and dealing with some of the hottest names in the sector. Because of its forward-thinking attitude, it has drawn the attention of many major mainstream players, including the company behind Marlboro, Altria Group.

On December 7th, rumors were finally confirmed when Cronos made the official announcement of a C$2.4 billion strategic investment from Altria. “Altria is the ideal partner for Cronos Group, providing the resources and expertise we need to meaningfully accelerate our strategic growth,” said Cronos Group’s Mike Gorenstein, Chairman, President and Chief Executive Officer.

By. Joao Piexe

IMPORTANT NOTICE AND DISCLAIMER

PAID ADVERTISEMENT. This communication should be viewed as a paid advertisement. Leacap Ltd and Safehaven and their owners, managers, employees, and assigns (collectively “the Publisher”) is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher was not specifically paid for this communication. However, a related company was previously compensated by Tru Trace Technologies In May 2018, to produce and disseminate other similar articles and certain banner ads. This compensation should be viewed as a major conflict with our ability to be unbiased.

Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur.

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on an interview conducted with the company’s CEO, and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.

SHARE OWNERSHIP. The owner of Safehaven owns shares and/or stock options of the featured companies and therefore has an additional incentive to see the featured companies’ stock perform well. The owner of Safehaven has no present intention to sell any of the issuer’s securities in the near future but does not undertake any obligation to notify the market when it decides to buy or sell shares of the issuer in the market. The owner of Safehaven will be buying and selling shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

FORWARD LOOKING STATEMENTS. This publication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. The publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the companies’ actual results of operations. Factors that could cause actual results to differ include, but are not limited to, changing governmental laws and policies, the success of the companies’ technology, the size and growth of the market for the companies’ products and services, the companies’ ability to fund their capital requirements in the near term and long term, pricing pressures, etc.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

TERMS OF USE. By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://Safehaven/terms-and-conditions If you do not agree to the Terms of Use http://Safehaven/terms-and-conditions, please contact Safehaven to discontinue receiving future communications.

INTELLECTUAL PROPERTY. Safehaven is the Publisher’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.

Wednesday, July 10th, 2019 Uncategorized Comments Off

$CNPOF $RIV $RIV.V Receipt of Five New AGLC Cannabis Retail Licenses

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced that its portfolio company, YSS Corp. (TSXV: YSS) (WKN: A2PMAX), has received five cannabis retail licenses from the Alberta Gaming, Liquor and Cannabis Commission (“AGLC”). Per the update, the five new licenses will operate under the YSS(TM) brand name and are located throughout Alberta. “YSS has made tremendous progress building up their retail presence in Alberta – doubling their current AGLC licensed stores to ten,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “With plans to have all ten stores open by the end of August, this announcement represents positive momentum for YSS in the second half of 2019.”

To view the full press release, visit: http://nnw.fm/7eSEV

About Canopy Rivers Inc.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://nnw.fm/CNPOF

About NetworkNewsWire

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, July 10th, 2019 Uncategorized Comments Off

$NETE Teen Marijuana Use Reduces When Recreational Use Laws Are Passed, Study

A newly published research paper is suggesting that while the overall number of young people who use marijuana has increased over the years, there appears to be a reduction in teen marijuana use in states where recreational cannabis has been legalized.

The legalization of recreational cannabis has been linked to an 8 percent drop in the number of high school teens who confessed that they had used marijuana in the past 30 days. There was also a 9 percent drop in high schoolers who reported that they had used cannabis a minimum of 10 times in the past 30 days.

Mark Anderson, the lead author of the study which was published on Monday this week, said that it was important for people reading the research findings to note that the researchers didn’t find any link between the prevalence of teen marijuana use and the passing of medical cannabis laws in different states.

The researchers also stressed that the study doesn’t suggest that when recreational marijuana laws are passed, then teen cannabis use drops. The study only points to an association, not causation.

The findings of the study were arrived at after analyzing the annual Youth Risk Behavior Surveys done by the U.S. CDC. The researchers specifically looked at the data collected between 1993 and 2017. This data included information on 1.4 million high schoolers.

The researchers zeroed in on the responses about marijuana use before recreational cannabis laws were passed and after legalization. The same was done for areas where medical marijuana laws were enacted.

The researchers believe that their findings are the most reliable on the matter, but they also added that many states didn’t have recent self-reported data on teen marijuana use since legalization laws had only started being implemented recently. They therefore vowed to update their statistics after a few more years to reflect the data sets on the states where recreational marijuana has recently been legalized.

However, this study seems to contradict what other studies have found. For example, the Criminal Justice Department in Colorado found that there was no change in teen marijuana use from the time recreational marijuana was legalized five years ago.

Commenting on this recent study, scientists have wondered why that drop in high schoolers using marijuana has been observed. Some suggested that when adult-use marijuana is legalized, it becomes harder to get cannabis off the streets, and this could limit teen access to the substance. It would be interesting to hear what marijuana companies like Net Element Inc. (NASDAQ: NETE) and Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) have to say about this potential explanation for the drop in teen marijuana use.

More research needs to be done to establish what exactly is causing the drop in teen marijuana use in places where recreational marijuana is legal.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Wednesday, July 10th, 2019 Uncategorized Comments Off

$OGI and Lift & Co. Enhance Education of Cannabis Frontline Staff

MONCTON, New Brunswick

● Organigram first licensed producer in Canada to deliver brand education through CanSell platform to front-line retailers

● CannSell, available to retailers in eight jurisdictions is the sole, mandatory approved training program for all cannabis retail staff in the Province of Ontario

● CanSell Certification program developed in partnership with MADD Canada

Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a collaboration with Lift & Co. Corp (“Lift & Co.”) (TSXV: LIFT) (OTCQB: LFCOF) to support the launch of Canada’s first branded cannabis educational program via Lift & Co.’s CannSell retail training program.

CannSell’s retail certification program, developed in partnership with MADD Canada to promote the responsible sale of cannabis, is available in seven provinces and one territory. CannSell stands as the sole mandatory, provincially-approved cannabis training program for all Ontario retail workers. Organigram is the first licensed producer in Canada to partner with Lift & Co. on educational content on the platform focusing on the Company’s unique growing processes and product attributes.

“Education and public safety are top priorities for Organigram. We’re pleased to partner with Lift & Co. on this module, which will ensure that thousands of front-line retail staff receive up-to-date and essential information about safe consumption, high-quality cannabis products and important regulations,” says Greg Engel, CEO, Organigram. “It’s no secret that producers face challenges reaching consumers in this highly-regulated environment; connecting with and educating retail staff provides a unique opportunity to bring our brand messages to life right in the places consumers are making purchase decisions.”

The rollout of the Organigram-branded module, which began in June, will deliver digital training on Organigram’s unique, three-tiered growing methodology, best practices and Edison Cannabis Co. and Edison Reserve products to budtenders across Canada.

“We opened up our CannSell platform to allow select brands, such as Edison Cannabis Co., to develop digital education modules for retail budtenders that showcase their brands and contribute to the education of consumers,” says Matei Olaru CEO Lift & Co. “This module will allow Organigram to connect directly with budtenders at any time and educate retail staff about their product attributes, best practices and stay top-of-mind with budtenders – the only people in the value chain speaking directly with consumers.”

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

About Lift & Co.

Lift & Co. (TSXV: LIFT) is a publicly-traded technology company modernizing the cannabis industry.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company and Lift believe that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company and Lift disclaim any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. We seek safe harbor.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190710005366/en/

For Organigram Investor Relations enquiries, please contact:

Amy Schwalm
Organigram
Vice President, Investor Relations
Amy.Schwalm@organigram.ca
(416) 704-9057

For Organigram Media enquiries, please contact:

Ray Gracewood
Organigram
Senior Vice President, Marketing and Communications
rgracewood@organigram.ca
(506) 645-1653

For Lift & Co. Investor Relations enquiries, please contact:
Prit Singh
Thesis Capital
psingh@thesiscapital.ca
(905) 510-7636

For Lift & Co. Media enquiries, please contact:
Sara McMillen
Director, Communications and Government Relations
Lift & Co.
smcmillen@lift.co
(416) 220-9536

Wednesday, July 10th, 2019 Uncategorized Comments Off

Archive for July, 2019

$TGODF Aims to Establish Significant Presence in Global Hemp, CBD Market

$YGYI Featured in CannabisNewsWire, CBD Industry’s ‘Sweet Spot’

$INMB Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease

$GGBXF Featured in CannabisNewsAudio Broadcast on Popularity of ‘Cannabis Beauty’

$YGYI Smart Companies Finding Sweet Spot in Cannabis Processing, Manufacturing Opportunities

$OGI Brand Innovation Key to Leading in Cannabis-Infused Beverages

$LXRP DehydraTECH Consistently Outperforms Industry Standards

$TCAN TransCanna Holdings Inc. Adds Top-Tier Executive to Ranks

$PBIO Flagship Barocycler 2320EXTREME Featured at International Conference in China

$PBIO Delivers Custom Ultra Sheer Instrument to Ohio State for Food Safety Research

$INMB XPro1595 May Reduce Risk of Alzheimer’s, Report Suggests

$GGBXF Featured in CannabisNewsWire, Mainstream Retailers Making Room for CBD

$GGBXF Waves of #CBD Beauty Products Filling Shelves of Major Retailers Across the US

$CNPOF $RIV.V $RIV Releases Q4, FY19 Financial Highlights; Corporate Update

$INMB Helping to Drive Alzheimer’s Disease Market Growth

$NUGS Senate Could Hold Hearings on Cannabis Banking Later this Month

$TGODF 10,000 Licenses Issued, California Reflects the Growing Power of Hemp

$OGI Expanding Capacity, CBD Beauty Product Wave Hits Retail

-also-

$LXRP Live Investor Presentations Now Available for On-Demand Viewing

$VVCIF Ballot Measure to Legalize Recreational Marijuana in Arkansas

$TGODF Millennials Investing in a Green Future: Cannabis to Solar

$OGI Reports Q3 Fiscal 2019 Results, Hosts Earnings Call

$TGODF Debuts Global Strategic Hemp Division, Organic Certification

$GGBXF Announces Agreement with American Eagle to Sell CBD-Infused Personal Care Products

$OGI Toxic, Low-Quality CBD Products Putting Consumers at Risk

$LXRP DehydraTECH to be Leveraged Through CBD License Agreement with Universal Hemp

$TGODF Tech Companies Transforming The Cannabis Industry

$CNPOF $RIV $RIV.V Receipt of Five New AGLC Cannabis Retail Licenses

$NETE Teen Marijuana Use Reduces When Recreational Use Laws Are Passed, Study

$OGI and Lift & Co. Enhance Education of Cannabis Frontline Staff

TraderPower Featured Companies

Top Small Cap Market News

Recent Posts

Recent Comments

Archives

Categories

Meta